The Impact of Inflammatory Adhesion on the Prognosis of Colon Cancer Patients
The Impact of Tumor-associated Inflammatory Adhesion on the Prognosis of Colon Cancer Patients: a Study Based on the SEER and Chinese Multi-center Databases
1 other identifier
observational
229
1 country
1
Brief Summary
The purpose of this study is to explore the impact of tumor-associated inflammatory adhesion on the prognosis of colon cancer patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 22, 2024
CompletedFirst Posted
Study publicly available on registry
October 23, 2024
CompletedStudy Start
First participant enrolled
October 24, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 26, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 27, 2024
CompletedNovember 7, 2024
November 1, 2024
2 days
October 22, 2024
November 6, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Overall survival time (OS)
OS, defined as the time from the first diagnosis to death from any cause or the last follow-up for surviving patients
up to 10 years
Cancer-specific survival time (CSS)
CSS refers to the duration from diagnosis of a tumor until the patient succumbs to the tumor, excluding deaths from other causes.
up to 10 years
Recurrence free survival time (RFS)
RFS is the time from the time a patient achieved R0 resection after surgery to the time of recurrence or the end of follow-up.
up to 10 years
Study Arms (2)
the U.S. National Cancer Center SEER database
SEER\*Stat software (version 8.4.3) collected 17 registries cohort data on colon cancer patients between 2010 and 2019.
Chinese multi-center database
Chinese multi-center database includes patients from January 2010 to December 2021 at 3 institutions.
Interventions
This was a retrospective study and no patient intervention was performed.
Eligibility Criteria
This study utilized the Chinese multi-center database as well as the SEER 17 registries database. The Chinese multi-center database contains data of patients between January 2010 and December 2021, at 3 institutions. SEER\*Stat software (version 8.4.1.1) was used for collecting 17 registries cohort data on patients diagnosed with NMIBC between 2010 and 2019.
You may qualify if:
- The patient was pathologically diagnosed as colon adenocarcinoma by endoscopic biopsy before operation.
- All patients were considered to have tumors invading adjacent organs during surgery
- All patients underwent radical surgery.
You may not qualify if:
- \. Patients with distant metastasis, recurrent colon cancer and pT4b CRC were excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100021, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate professor
Study Record Dates
First Submitted
October 22, 2024
First Posted
October 23, 2024
Study Start
October 24, 2024
Primary Completion
October 26, 2024
Study Completion
October 27, 2024
Last Updated
November 7, 2024
Record last verified: 2024-11